Skip to content

    Harmony Biosciences Holdings (HRMY) stock price & financials

    View HRMY earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+3.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $186.04M
    $201.27M
    $184.73M
    $200.49M
    $239.46M
    +28.7%
    $243.78M
    +21.1%
    $215.39M
    +16.6%
    $261.28M
    +30.3%
    Strengthening
    Operating Profit
    $61.71M
    $55.73M
    $56.24M
    $48.18M
    $65.49M
    +6.1%
    $38.56M
    -30.8%
    $37.29M
    -33.7%
    $89.32M
    +85.4%
    Strengthening
    Net Profit
    $46.09M
    $49.48M
    $45.56M
    $39.78M
    $50.87M
    +10.4%
    $22.49M
    -54.6%
    $32.49M
    -28.7%
    $75.43M
    +89.6%
    Stable
    EPS
    $0.81
    $0.79
    $0.69
    $0.88
    +8.6%
    $0.56
    -29.1%
    $1.30
    +88.4%
    Strengthening
    Other Income
    Interest
    $4.35M
    $4.21M
    $3.84M
    $3.65M
    $3.62M
    -16.7%
    $3.55M
    -15.8%
    $3.23M
    -15.7%
    $3.07M
    -15.8%
    Weakening
    Depreciation
    Profit before Tax
    $62.17M
    $56.16M
    $57.18M
    $49.64M
    $67.49M
    +8.6%
    $40.76M
    -27.4%
    $39.69M
    -30.6%
    $93.27M
    +87.9%
    Strengthening
    MarginsOPM
    33.2%
    27.7%
    30.4%
    24.0%
    27.4%
    -17.5%
    15.8%
    -42.9%
    17.3%
    -43.2%
    34.2%
    +42.2%
    Weakening
    Tax
    25.9%
    11.9%
    20.3%
    19.9%
    24.6%
    -4.8%
    44.8%
    +276.7%
    18.1%
    -10.7%
    19.1%
    -3.8%
    Strengthening
    ReturnsROIC
    17.1%
    18.4%
    16.9%
    14.8%
    18.9%
    +10.4%
    8.4%
    -54.6%
    12.1%
    -28.7%
    28.1%
    +89.6%
    Stable

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$24.46M$228.63M$234.31M$243.78M$311.66M$453.00M$752.50M$549.77M
    Short-Term Investments
    Total Current Assets$31.50M$262.89M$284.44M$400.29M$451.07M$579.25M$907.01M$814.33M
    Net PP&E$1.33M$938.0K$4.12M$2.88M$2.71M$3.38M$5.34M$5.84M
    Goodwill
    Intangibles$72.19M$162.34M$143.92M$160.95M$137.11M$113.26M$89.42M$77.50M
    Total Assets$106.70M$427.07M$433.44M$673.87M$811.45M$999.20M$1.27B$1.37B
    LiabilitiesTotal Current Liabilities$19.89M$134.54M$53.77M$78.88M$163.78M$175.08M$252.13M$234.07M
    Short-Term Debt$2.00M$2.00M$15.00M$16.25M$20.00M$20.00M
    Long-Term Debt$97.95M$194.25M$189.98M$189.65M$178.57M$163.02M$143.66M$133.96M
    Long-Term Leases$2.23M$975.0K$1.08M$822.0K$4.51M$4.78M
    Total Liabilities$118.29M$329.89M$246.94M$271.03M$344.46M$340.05M$401.41M$373.84M
    EquityCommon Stock & APIC$1.0K$1.0K$1.0K$1.0K$1.0K$1.0K$1.0K
    Retained Earnings-$422.86M-$488.19M-$453.60M-$272.13M-$143.28M$2.22M$160.90M$268.82M
    Total Equity-$422.86M$97.18M$186.51M$402.84M$466.99M$659.15M$870.22M$999.24M
    HighlightsNet Cash / (Debt)$42.33M$52.14M$118.09M$273.74M$588.84M$395.81M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$75.44M-$2.98M$98.56M$144.47M$219.39M$219.82M$348.20M$355.08M
    Cash from Investing-$127.15M-$2.00M-$100.30M-$141.83M-$46.44M-$67.48M-$39.65M-$337.57M
    Cash from Financing$143.77M$209.16M$7.42M$6.84M-$105.55M-$11.00M-$9.05M-$13.79M
    SummaryCapital Expenditure-$149.0K-$2.0K-$298.0K-$172.0K-$312.0K-$1.15M-$310.0K
    Free Cash Flow-$75.58M-$2.99M$98.26M$144.29M$219.07M$218.67M$347.89M
    FCF Margin-1260.8%-1.9%32.2%33.0%37.6%30.6%40.1%

    Ratios